159,818 Shares in M3-Brigade Acquisition V Corp. $MBAV Bought by BCK Capital Management LP

BCK Capital Management LP acquired a new position in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 159,818 shares of the company’s stock, valued at approximately $1,686,000. M3-Brigade Acquisition V accounts for 1.8% of BCK Capital Management LP’s portfolio, making the stock its 11th largest position. BCK Capital Management LP owned about 0.44% of M3-Brigade Acquisition V at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in MBAV. Sandia Investment Management LP purchased a new stake in shares of M3-Brigade Acquisition V during the second quarter worth about $334,000. Clear Street LLC increased its stake in M3-Brigade Acquisition V by 2,280.8% during the 2nd quarter. Clear Street LLC now owns 32,069 shares of the company’s stock worth $362,000 after buying an additional 30,722 shares in the last quarter. Levin Capital Strategies L.P. acquired a new position in shares of M3-Brigade Acquisition V during the second quarter valued at approximately $538,000. Bluefin Capital Management LLC purchased a new position in shares of M3-Brigade Acquisition V in the second quarter valued at approximately $690,000. Finally, JPMorgan Chase & Co. acquired a new stake in shares of M3-Brigade Acquisition V in the second quarter worth approximately $900,000.

Insider Activity

In related news, major shareholder Fitzgerald & Co. Cantor bought 3,529,081 shares of the business’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of $10.80 per share, with a total value of $38,114,074.80. Following the purchase, the insider directly owned 7,779,865 shares of the company’s stock, valued at $84,022,542. The trade was a 83.02% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, M3-Brigade Acquisition V currently has an average rating of “Sell”.

M3-Brigade Acquisition V Stock Performance

MBAV stock opened at $10.66 on Friday. M3-Brigade Acquisition V Corp. has a 1 year low of $10.14 and a 1 year high of $13.73. The business has a 50 day simple moving average of $10.68 and a 200-day simple moving average of $10.61.

M3-Brigade Acquisition V Company Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.